chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash in her face, legs and knuckles,that was also itchy), FEELING HOT (rash in her face and knuckles,that was hot and itchy) and RASH PRURITIC (rash in her face and knuckles,that was hot and itchy) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included GLUCOSAMINE and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced RASH PRURITIC (rash in her face, legs and knuckles,that was also itchy). In March 2021, the patient experienced FEELING HOT (rash in her face and knuckles,that was hot and itchy) and RASH PRURITIC (rash in her face and knuckles,that was hot and itchy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash, at an unspecified dose and frequency. At the time of the report, RASH PRURITIC (rash in her face, legs and knuckles,that was also itchy), FEELING HOT (rash in her face and knuckles,that was hot and itchy) and RASH PRURITIC (rash in her face and knuckles,that was hot and itchy) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
fever at night time; tired; chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), CHILLS (chills) and PYREXIA (fever at night time) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced FATIGUE (tired) and CHILLS (chills). On 15-Mar-2021, the patient experienced PYREXIA (fever at night time). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 13-Mar-2021, FATIGUE (tired) and CHILLS (chills) had resolved. On 16-Mar-2021, PYREXIA (fever at night time) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, SARS-CoV-2 test: positive (Positive) POSITIVE.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.
approx 4 hrs p/receiving vax pt had 2 brief episodes of pallor, hypotonia & hyporresponsiveness; mom called & instructed to bring pt back to MD; nl exam 1 hr p/events;
Admitting Physician: MD Discharge Attending Physician: Dr.  Primary Care Physician at Discharge: MD  Admission Date: 9/29/2022 Discharge Date: 9/30/2022   HOSPITAL COURSE: Patient is  a 20 y.o. female who presented on 9/29 as a level 2 trauma activation after being struck by a vehicle going approximately 40 mph.  She sustained multifocal SAH, R frontal bone fracture, R sacral alar fracture, and large R forehead hematoma.  She was admitted to trauma.  Neurosurg was consulted; repeat head CT was stable and neuro checks were stable.  She was started on a clear liquid-- >general diet which she tolerated.  Her tertiary exam revealed no additional injuries.  For her R sacral ala fracture, ortho was contacted.  No formal consult was placed as this was a very small fracture and she ambulated without issues.  Plastics was consulted for her frontal sinus fx and abrasion; this was managed with elevated HOB, ice, and baci to the abrasion TID.  Neuropsych was consulted and did not require outpatient therapy.  PT/OT was consulted but she was ambulating without assistance and was okay for discharge home.  By discharge, her pain was stable with PO pain meds, she was tolerating a diet, she was ambulating as above, and she was urinating spontaneously without any issues.  The patient was discharged to home on 9/30 in stable condition.  Prior to discharge, discharge instructions were discussed with the patient and all questions were answered.  PRESENTING PROBLEM and ADMISSION DIAGNOSIS Subarachnoid hemorrhage [I60.9] Abrasion of scalp, initial encounter [S00.01XA] Closed fracture of frontal bone, initial encounter [S02.0XXA] Closed fracture of sacrum, unspecified portion of sacrum, initial encounter [S32.10XA] COVID-19 [U07.1] Subarachnoid hemorrhage
First Moderna vaccine on 1-3-2021; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Moderna vaccine on 1-3-2021) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Moderna vaccine on 1-3-2021). On 03-Jan-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First Moderna vaccine on 1-3-2021) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Relevant concomitant product usage were not reported by the reporter. No treatment details were added. Action taken with mRNA-1273 in response to the event was not applicable.
After receiving TD and returning to checkout counter, pt fainted and fell to the floor and hit his head on floor. Eyes rolled to back of head and posturing. BP-160/60, responding in a matter of seconds. Conscious. Ambulance called and client was conscious when EMS arrived and declined being transported to the hospital. He was taken by private car to be examined. Mom took by private car.
Left shoulder pain, unable to lift arm then developed low grade fever, delirium and admission to hosptial for observation.
Vaccine response impaired; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION FAILURE (Vaccine response impaired) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product UPADACITINIB (RINVOQ) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   In November 2020, the patient started UPADACITINIB (RINVOQ) (unknown route) 15 milligram. In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. In January 2021, the patient experienced VACCINATION FAILURE (Vaccine response impaired). At the time of the report, VACCINATION FAILURE (Vaccine response impaired) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 antibody test: negative (Negative) Found that body did not develop antibodies..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.   No treatment information was provided.  Company comment: This report refers to a case of vaccination failure for mRNA-1273, lot # unknown with no associated AEs.; Sender's Comments: This report refers to a case of vaccination failure for mRNA-1273, lot # unknown with no associated AEs.
Deltoid swelling, redness, warmth, pain x 3 days, treated with PCN to cover for cellulitis
Hives across legs, arms, and front torso. Large circular induration (~7 cm) at injection site. Reports of mild itchiness. Provided oral diphenhydramine 24hrs after symptom onset. VAERS report submitted on day 2 of symptoms.
I was unable to sleep and had interrupted sleep the night of vaccination. The next day, my eyeballs felt painful and it was difficult to focus at work.  I felt better the following day .However, my skin had broken out into a strange rash of almost pimple -like lumps all over my face and on my stomach. They are itchy and painful.
purpura within 48 hours.  faded within a week.  Weight gain of 1 pound per month despite healthy diet and reduction in calories.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 68-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of pain in extremity (and redness experienced after receiving 1st dose on 15th September 2018, refer case US2018208389).  On 14th November 2018, the patient received the 2nd dose of SHINGRIX 50 mcg/mg. On 15th November 2018, 1 days after receiving SHINGRIX, the patient experienced pain in arm, headache and chills. On an unknown date, the outcome of the pain in arm, headache and chills were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, headache and chills to be related to SHINGRIX. Additional details were received as follows: At the day of reporting, in the morning the patient presented with soreness in am along with headache and chills. With the headache and chills she was concerned if she was getting the flu so she saw her health care professional (HCP). Flu and strep tests were both negative. Emergency visit was required.  The reporter did not consent to follow up.
Headache, chills, joint pain, fatigue and fever starting approximately 20 hours after vaccination and resolved 30 hours after vaccination
(Son) called Saturday 12/28 late afternoon to say patient had broken out in a "rash" / "bumps" on arms, legs, torso. Pharmacist recommended Benadryl and follow up with doctor. Son called Sunday 12/29 morning to say "rash" was not getting worse, but was still there. Pharmacist advised follow up with doctor. Pharmacist left message for patient Monday 12/30 morning to follow up. She also contacted the doctor's office. Patient notes at doctor  indicated that she visited the urgent care Sunday, and was feeling better on Monday.
Patient eyes rolled back and his arms became still and hands turned outward.  It lasted 5 -10seconds.  Patient was alert and oriented to person and place within 10 seconds.  He complained of being tired immediately afterward.  Patient drank some cold water and was seen by a pediatrician in the clinic.  Neurology referral placed for patient to follow up.
Severe right shoulder pain limiting range of motion, and going into shoulder blade.  Vax on 9/26.  On 9/28, went to chiropractor as shoulder was hurting.  Chiro reported inflammation.  On 10/6 attempted massage for shoulder pain and couldn?t complete as it was too painful.  On 10/10, went to PCP Dr who said shoulder felt ?like a brick? and she prescribed muscle relaxers and PT.  Started PT on 10/12 and given a Rx plan of at least 8 weeks for 2 x per week.  Some improvement with PT and muscle relaxers, but not what I would expect so made an appt with Rheumatologist on 10/26 to see if the pain could be RA related.  It was at this appointment that the Dr did a timeline with me and we put it together that the pain started after the Covid vaccine I received in my right arm in September.  After realizing this, I thought back to the vaccine and remembered that there was more pain during the injection, blood at the injection site (not typical for me) and a small bruise at the injection site that lasted for over a week (at the time I assumed it was just that I bruise easier bc of meds).
Pt noticed onset of symptoms, 3 days post vax, with swelling and itching at the injection site. He was prescribed steroid cream.
History of fear of needles, feeling faint after receiving the J&J vaccine. SOB 97.9 , B/P - Refused, p-88 . R-19
This spontaneous report was received from a healthcare worker referring to a 3 month old patient of unknown gender. The patients' concurrent conditions and medical histories were not provided. On 28-OCT-2015, the patient was vaccinated with a dose of improperly stored ROTATEQ orally (dose was unknown, lot # K023532, expiration date 21-JUN-2016). Concomitant medication was not reported. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
MILD-- > on 23 April, 8-9 days post shot, noticed new redness, swelling, mild itching at injection site plus some tenderness around armpit area in same arm . currently on 24 April it is continuing but reness and swelling seems to have started going down (arm sorenes/heaviness was noted for 2 days alter shot, but had resolved after 3 days)
Pt continued to be very fussy from time of administration; About 12noon started w/reddened area around vax area; took pt to MD, gave APAP;
This spontaneous report was received from a certified medical assistant refers to a patient of unknown age. The reported stated that the patient was vaccinated with the first dose, of 0.5 ml VAQTA (lot # not reported) on 27-JAN-2009 and 3 months later on 27-APR-2009, was vaccinated with the second dose, of 0.5 ml VAQTA (lot # not reported). No adverse effect reported. Additional information has been requested.
left leg has "fallen asleep from the buttock area and down his left leg"; when he walks it is not a natural motion, it's a forced; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021 at 12:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced). At the time of the report, PARAESTHESIA (left leg has "fallen asleep from the buttock area and down his left leg") and GAIT DISTURBANCE (when he walks it is not a natural motion, it's a forced) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant drugs were reported. No treatment medications were reported.
13 yo m bib FOP at insistence of MOP for concerns of perceived facial swelling, most notably around superior eyebrow/lid of R eye, lesser on L eye and b/l cheeks, acute onset 3hrs pta noticed by MOP while eating dinner (pizza, which Pt has had previously); pt has hx of mild environmental allergies for which he takes zyrtec but Pt and FOP deny hx of severe/anaphylactic rxn or use of epipen/hospitalization; Pt states perceives mild swelling of this area only after MOP mentioned it, denies any frank pain or irritation sx's at this time; Pt denies any cp, sob, dyspnea, throat swelling/difficulty swallowing/talking, other rashes/lesions, sore throat, urinary color changes, fevers/ns/chills. FOP mentions that Pt received.  FOP mentions that Pt received Pfizer vaccine for covid19 approx 24hrs pta and additionally has recently up-titrated anti-seizure Rx, and MOP was worried about rxn to these things (specifically describes SJS/TENS)  ROS:  General: No fatigue, fevers/chills, malaise Eyes: facial swelling; No eye pain, eye discharge, visual changes Ears: No ear pain, hearing changes Nose/throat: No nasal congestion, sore throat CV: No chest pain, palpitations, syncope, edema Pulm: No SOB, wheezes, cough, hemoptysis GI: No anorexia, abd pain, nausea, vomiting, diarrhea GU: No dysuria, hematuria, urgency, frequency Neuro: No HA, seizures, weakness, numbness/tingling, vertigo, lightheadedness, AMS Skin: No rash, lesions, itching Heme: No easy bruising/bleeding, petechiae All systems reviewed and negative except as stated above.  Physical Exam: Vital signs reviewed, no acute intervention necessary General: NAD, WNWD, AOX3, cooperative Head: Normocephalic, atraumatic Eyes: mild edema of R superior lid w/o erythema/ttp/warmth; no other visible orbital edema of L or R orbits; no perceived edema of cheeks/rest of face; PERRL, EOMI, no conjunctival injection, no scleral icterus Ears: No edema/erythema of otic canal, no TM edema/erythema/dullness/bulging Nose: No nasal discharge Throat: No pharyngeal edema, erythema, tonsillar exudates, uvular deviation, asymmetric swelling, trismus, drooling, or voice changes Neck: No meningismus; normal ROM Lymph: No cervical lymphadenopathy Respiratory: Unlabored breathing, normal respiratory effort, LCTAB CV: Normal peripheral circulation, RRR, no m/r/g Abd: Soft, NTND Skin: No rashes, petechiae, or purpura Neuro: Grossly intact, moves all extremities equally, gait normal MSK: No TTP, deformity, ecchymosis, or focal edema Psych: Normal mood, normal affect, appropriate responses
Patient reported difficulty breathing, chest tightness, chest pain and headache about 5 minutes after receiving her first Moderna shot.  Patient was given oral benadryl at 4:56 pm and monitored by RPh.  At 5:20pm patient reported that her symptoms have improved and was told to continue to monitor her breathing at home.  Patient was called later that evening around 7pm but no answer.  Patient was called again at 10am the following day and patient reported that her symptoms continued to improve over 2 hours after her vaccine. The morning following she had no breathing or chest issues only reported pain and soreness at injection site.
3/18/08 MOTHER IN FOR 6 MONTH VACCINATIONS AND REPORTED THIS EVENT HAPPENED AFTER 1ST SET OF VACCINES ON 11/15/07 AND AGAIN AFTER 2ND SET OF VACCINES ON 1/15/08, STATING SYMPTOMS WERE A LITTLE WORSE AFTER THE 2ND SET OF SHOTS. SHE STATES SHE DID NOT REPORT IT EARLIER BECAUSE SHE DID NOT THINK IT WAS ALL THAT UNUSUAL. CONTINUOUS CRYING STARTED 45 MIN TO 1 HR AFTER INJECTIONS, LASTING 2 OR 3 HRS. THEN CHILD COULD BE CONSOLED FOR 5-10 MIN AT A TIME & TAKING A LITTLE NAP, BEFORE CRYING STARTED AGAIN. THIS OFF & ON CRYING CONTINUED THROUGH THE NIGHT UNTIL ABOUT NOON THE NEXT DAY. ELEVATED TEMP (HIGHEST 101 AX) STARTED SEVERAL HOURS AFTER INJECTIONS AND CONTINUED FOR ABOUT 2 DAYS. MOTHER ALSO STATED THAT STARTING ABOUT 2 HRS AFTER THE INJECTIONS, CHILD HAD OCCASIONAL EPISODES OF "THROWING HERSELF BACKWARDS" HAVING ARCHED BACK, AND THIS LASTED THROUGHOUT THE NIGHT. CHILD CONTINUED TO BE WHINY WITH SLIGHT ELEVATED TEMP. ON DAY 2 AFTER THE INJECTIONS, AND ON DAY 3 AFTER INJECTIONS, SHE WAS BACK TO NORMAL, WITH NO PROBLEMS AFTERWARDS. 3/18/08 HER 6 MONTH VACCINES (IPV, COMVAX, PREVNAR AND ROTAVIRUS) WERE GIVEN, BUT DTAP WAS NOT GIVEN. OUR NURSE INSTRUCTED HER TO TALK WITH HER PEDIATRICIAN RE/RECEIPT OF ANY MORE PERTUSSIS. 3/24/08 SPOKE WITH MOTHER BY PHONE RE/ANY PROBLEMS AFTER VACCINES GIVEN ON 3/18/08. SHE STATED NO PROBLEMS AFTER HER 3/18/08 SHOTS. STATED SHE GAVE PATIENT DOSE OF TYLENOL AFTER INJECTIONS AND ANOTHER DOSE 4 HOURS LATER, THAT PATIENT TOOK A NAP AND WOKE UP FINE, AND HAS BEEN WELL SINCE.
pt recv vax 31OCT97 & w/in 2 days of vax pt exp cellulitis;
I went to the vaccine shot and we were crammed in there. I got the shot and I went home and I felt fine and then 11 that night I started to get a fever and chills and I started ranting, yelling couldn?t get to sleep the next day everything was gone. I started to have a small cough on Sunday morning. On the Monday I went to a college visit when my daughter to  and I didn?t feel bad at this time I was masked for most of the time. And Tuesday morning I woke up and had a sore throat and a cough that grew in to some body aches and I contacted the doc I lost my sense of taste and smell I contacted a doctor telehealth who set up and a covid test (positive) . From the time that I was not feeling well I did separate my self from everyone. The aches lasted for about 5/6 days and the body aches I did have a lingering cough. My instructions were to stay out 10 days starting 04/02 and I could go back to work on 04/12 if I was fever free and the other symptoms were improving
a patient who received 2 doses of Arexvy vaccine.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 70-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number EP5FD, expiry date 07-DEC-2024) and (batch number 9R25L, expiry date 21-MAR-2025) for prophylaxis.   Concomitant products included RSV vaccine prot. subunit PreF3 (Arexvy).   On 14-NOV-2023, the patient received the 2nd dose of Arexvy. On 14-NOV-2023, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: a patient who received 2 doses of Arexvy vaccine.). The outcome of the extra dose administered was unknown.   Additional Information: GSK Receipt Date: 14-NOV-2023 The pharmacist requested data regarding potential adverse effects for a patient who received 2 doses of Arexvy vaccine. The patient received 1st dose on 08-SEP-2023 and 2nd dose on 14-NOV-2023, which led to extra dose administered. The reporter consented to follow up.
At injection site, whole upper arm became red; At injection site, whole upper arm became swollen; hypersensitive; This case was reported by a physician via sales rep and described the occurrence of injection site erythema in a 55-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th December 2021, the patient received the 1st dose of Shingrix. In December 2021, less than a week after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and hypersensitive skin. The patient was treated with benadryl (nos) (Benadryl). On an unknown date, the outcome of the injection site erythema, injection site swelling and hypersensitive skin were recovered/resolved.   It was unknown if the reporter considered the injection site erythema, injection site swelling and hypersensitive skin to be related to Shingrix.  Additional details were reported as follows: Age at vaccination was not reported. The patient received dose of Shingrix injection site patients whole upper arm became red and swollen, which lasted until Saturday 11th December 2021. Patient was hypersensitive and took Benadryl. Benadryl was administered as treatment as a result of the hypersensitivity of the patient and, if it was administered 4 days after on Saturday as the injection site erythema and swelling was still present.
I began itching at the nape of my neck then all over my trunk and arms.  I became hoarse, had visible muscle spasms, and my teeth began to chatter uncontrollably.
I started to have chills the same day and it continued for three days. My lymph gland started to swell and I was running a fever. That Monday my fever went up to 108. I was also so tired and I could barely walk. I continued to run a fever until 02/05, but I was still tired and had extreme diarrhea and swollen glands. Covid rash on the left arm for about 6 days.
I experienced Intense vertigo this morning. Before today only  mild symptoms ( feeling rundown and headache) My husband had fever for 2 days)  I believe my husband and I had COVID 1 year ago( just 2 weeks before it was known. We thought it was flu, weren?t  tested)
t100 oral @ 11PM 23APR97;pt woke & c/o arm hurting;red, swollen next AM-arm still red & swollen but felt itchy;no tx x/APAP on 23APR97 @ 11PM;seen in office 1030AM 23APR97;lt deltoid area red area 65mm x 75mm indurated, warm, firm to touch;